2:55 PM
Mar 22, 2019
 |  BC Extra  |  Financial News

Hookipa proposes IPO as its cancer vaccines head towards the clinic

Infectious disease and cancer vaccine company Hookipa proposed Friday to raise up to $86.3 million in an IPO on NASDAQ.

Hookipa Pharma Inc. (New York, N.Y.) is developing vaccines using its VaxWave and TheraT viral vector platforms, both of which...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >